The V Foundation Translational grant supports Dr. Wechsler-Reya's innovative research in identifying new targets and potential therapies for pediatric brain tumors.
Ben Izar, MD, PhD, joins this cohort with an award of $1.25 million to continue the transformative work in his lab to enhance T cell function in cancer immunotherapy.
Four Columbia University faculty members have been named as 2024 Velocity Fellows and awarded pilot grants to support their early-stage cancer research.
The HICCC is pleased to announce a fifth Irving Cancer Drug Discovery Program (ICDDP) project, designed to help faculty accelerate cancer research discoveries.
A new three-year, $2.5 million grant from Stand Up to Cancer (SU2C) has been awarded to a multi-institutional team of gastroesophageal cancer experts, led by HICCC director Anil K. Rustgi, MD.
Nine clinical investigators and trainees at the Herbert Irving Comprehensive Cancer Center will receive awards from Conquer Cancer®, the ASCO Foundation, this year at ASCO's 2023 Annual Meeting
Dr. Izar has been selected as a recipient of the Pershing Sohn Prize in recognition of his innovative approach to finding a new therapeutic target for brain metastasis.
With grant support from the V Foundation, Dr. Cheng will pursue innovative research studying the interface of nutritional and gene regulatory networks in cancer.
Cory Abate-Shen, PhD, an internationally-recognized expert in genitourinary cancer, has been selected as the 2023 recipient of the AACR's Women in Cancer Research Charlotte Friend Lectureship.